Buoy Health has closed a $6.7 million Series A round led by F-Prime Capital Partners, formerly Fidelity Biosciences, with participation from FundRx and angel investors including Jack Connors, according to a news release. The funding will be used to expand the staff of 10 to 19 with additional clinical researchers, engineers, and marketers in the next 12 months. The business also wants to add to its customer base of hospitals and payers beyond Boston. They offer a white labeled version of the company’s symptom tracker with their own brand. The company has raised $9.2 million to date.
The company’s symptom checker, which has been live since March 8, is also available to consumers. Depending on the diagnoses, Buoy Health has eight triage level recommendations from staying at home to calling an ambulance. Some other recommendations include seeking primary care, urgent care, a nurse triage line or telemedicine.
The questions Buoy Health’s program asks, based on patient search criteria, stem from the most common diagnoses. Each question from the patient causes follow up questions to be “re-ranked”. Le likened the machine learning software its program uses to the way Netflix’s app makes recommendations based on the films users watch.
He noted that the goal is to figure out which questions will reduce the number of diagnoses the most. “By creating that granular understanding of medicine, the more patients we see, the better we get,” Le said.